Liquidia (LQDA) Common Equity (2019 - 2026)
Liquidia (LQDA) posted quarterly Common Equity of $108.6 million for Q1 2026, up 118.41% year-over-year from $49.7 million in Q1 2025, and up 142.65% quarter-over-quarter from $44.7 million in Q4 2025.
Liquidia (LQDA) Common Equity (2019 - 2026) Analysis & Trends
Liquidia's Common Equity history runs 8 years deep, the most recent figure standing at $108.6 million for Q1 2026.
- In Q1 2026, Common Equity rose 118.41% year-over-year to $108.6 million; the TTM figure through Mar 2026 stood at $108.6 million (up 118.41% YoY), while the FY2025 annual figure was $44.7 million, down 43.63% from the prior year.
- Common Equity for Q1 2026 stood at $108.6 million, up from $44.7 million in the prior quarter.
- The five-year high for Common Equity was $112.8 million in Q3 2024, with the low at $15.2 million in Q2 2025.
- The 5-year median for Common Equity is $72.8 million (2024), against an average of $69.6 million.
- The sharpest annual moves came in 2024 and 2025: Common Equity jumped 134.89% in 2024, then sank 80.44% in 2025.
- Liquidia's Common Equity stood at $90.4 million in 2022, then plunged by 47.7% to $47.3 million in 2023, then soared by 67.84% to $79.4 million in 2024, then tumbled by 43.63% to $44.7 million in 2025, then soared by 142.65% to $108.6 million in 2026.
- Business Quant data shows LQDA's Common Equity at $108.6 million in Q1 2026, $44.7 million in Q4 2025, and $22.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 4.05 Bn |
| 10 | Liquidia | 6.37 Bn | 6.09 Bn | 160.92 Mn | 195.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 195.11 Mn |
| Mar 31, 2026 | 108.58 Mn |
| Dec 31, 2025 | 44.75 Mn |
| Sep 30, 2025 | 22.05 Mn |
| Jun 30, 2025 | 15.19 Mn |
| Mar 31, 2025 | 49.71 Mn |
| Dec 31, 2024 | 79.38 Mn |
| Sep 30, 2024 | 112.76 Mn |
| Jun 30, 2024 | 72.84 Mn |
| Mar 31, 2024 | 97.11 Mn |
| Dec 31, 2023 | 47.29 Mn |
| Sep 30, 2023 | 48.01 Mn |
| Jun 30, 2023 | 60.66 Mn |
| Mar 31, 2023 | 81.64 Mn |
| Dec 31, 2022 | 90.42 Mn |
| Sep 30, 2022 | 95.03 Mn |
| Jun 30, 2022 | 102.11 Mn |
| Mar 31, 2022 | 55.39 Mn |
| Dec 31, 2021 | 65.27 Mn |
| Sep 30, 2021 | 72.96 Mn |